http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4962195-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bddb13507fe5dae90579df1d0504538d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22 |
| filingDate | 1989-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_857316bea27a082a9007b9031464b439 |
| publicationDate | 1990-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4962195-A |
| titleOfInvention | Solvate of cefadroxyl |
| abstract | The invention relates to a novel crystalline cefadroxyl hemihydrate having a K.F. between about 3.5 and 2.0%: such compound is more stable than other cefadroxyl molecules. The novel cefadroxyl is obtained preparing and isolating a novel cefadroxil solvate of dimethylacetamide, or of N-methyl-2-pyrrolidone or of monomethylformamide, slurrying said solvate with a mixture methanol/isopropyl alcohol 30:70 to 50:50 by volume at a temperature of about +45 DEG C. to +55 DEG C. and then filtering the so obtained compound. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005261335-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6337396-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006094771-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004035593-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077849-A1 |
| priorityDate | 1987-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.